Repeat Offender: Bioniche Pharma Gets 2nd Warning Letter for Sotradecol Promotion
This article was originally published in The Pink Sheet Daily
FDA says Bioniche must adopt new policies to monitor promotional activities because existing ones seem insufficient.
You may also be interested in...
Advertising rules for search engines, YouTube and blogs are among the topics for the two-day meeting.
Firms will need to redesign sponsored links that appear on Internet search engines or forgo using them at all, food and drug attorneys suggest following the agency's recent cluster of letters citing the promotions
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.